Brief: Bioventus Q3 Adjusted EPS USD 0.05
07/11/2023 12:00
Nov 07 (Reuters) - Bioventus Q3 adjusted EBITDA USD 21.7 million. * Q3 sales USD 120.8 million
Recent news on Bioventus
See all newsBioventus Inc. reports results for the quarter ended June 30 - Earnings Summary
Bioventus Q2 revenue misses estimates on surgical solutions decline
Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview
Bioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks